Funding
← Back to your selection

MSD Global Health Innovation Fund

Activity from announced rounds

Activity in this selectionOct 16, 2026 · Sep 17, 2026
Rounds participated in
1
Confirmed lead rounds
0
All roles disclosed
New companies
1
First participation on record · 0 follow-on
Funding in participating rounds
$34.4M
1 disclosed · full round size, not this investor’s share

By stage

Series A1

By primary sector

Enterprise software1

By country

France1

Rounds

1 in this selection
Biolevate

Biolevate automates evidence-based operational workflows for regulated life-sciences companies, helping enterprise teams organize and execute complex processes.

€30MSeries A
Participant